In summary, we have identified a signaling mechanism activated by the limitation in the availability of glutamine or its metabolism in glutamine-addicted tumor cells, which links GCN2/ISR activation with TRAIL-R2 upregulation. Here, EIF2AK4 is linked to neoplasm.